Vericel Stock

Vericel EBIT Margin

The EBIT Margin (Operating Margin) of Vericel (VCEL) as of Aug 16, 2026 is 4.00 %. In the previous year, EBIT Margin (Operating Margin) was 1.90 % — a change of 109.86% (higher).

EBIT Margin

4.00 %

YoY

109.86%

Last updated:

EBIT Margin (Operating Margin) of Vericel is 2026 4.00 % . EBIT Margin (Operating Margin) of Vericel was 2025 1.90 % . It decreases by 109.86% higher compared to the previous year.

For Vericel, the operating (EBIT) margin of 4.0% is up versus -5.0% a few years ago.

Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

EBIT Margin (Operating Margin) of Vericel is 4.00 % in 2026.

EBIT Margin (Operating Margin) of Vericel changed from 1.90 % to 4.00 %, representing a 109.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Vericel since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Vericel with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Vericel

All Key Metrics — Vericel